Co-Crystal Screening of Diclofenac

In the pharmaceutical industry, co-crystals are becoming increasingly valuable as crystalline solids that can offer altered/improved physical properties of an active pharmaceutical ingredient (API) without changing its chemical identity or biological activity. In order to identify new solid forms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Aakeröy, Christer B., Grommet, Angela B., Desper, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857085/
https://www.ncbi.nlm.nih.gov/pubmed/24310599
http://dx.doi.org/10.3390/pharmaceutics3030601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857085/
https://www.ncbi.nlm.nih.gov/pubmed/24310599
http://dx.doi.org/10.3390/pharmaceutics3030601

Ejemplares similares